Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Boris Kantor

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Advances in Genetics|October 15, 2014
Clinical applications involving CNS gene transferBoris Kantor, Thomas McCown, Paola Leone, et al.
Molecular Therapy. Methods & Clinical Development|May 13, 2017
Integrase-Deficient Lentiviral Vector as an All-in-One Platform for Highly Efficient CRISPR/Cas9-Mediated Gene EditingPavel I Ortinski, Bernadette O'Donovan, Xiaoyu Dong, et al.
Life Sciences, Society and Policy|October 12, 2020
Good problems to have? Policy and societal implications of a disease-modifying therapy for presymptomatic late-onset Alzheimer's diseaseMisha Angrist, Anna Yang, Boris Kantor, et al.
Gene|February 6, 2003
Characterization of the human Snrpn minimal promoter and cis elements within itYael Green Finberg, Boris Kantor, Alon Y Hershko, et al.
Pediatric Neurology|July 21, 2020
Viral-Mediated Gene Replacement Therapy in the Developing Central Nervous System: Current Status and Future DirectionsJulie Uchitel, Boris Kantor, Edward C Smith, et al.
Human Molecular Genetics|September 16, 2004
Establishing the epigenetic status of the Prader-Willi/Angelman imprinting center in the gametes and embryoBoris Kantor, Yotam Kaufman, Kirill Makedonski, et al.
Frontiers in Molecular Neuroscience|September 9, 2020
Gene-Editing Technologies Paired With Viral Vectors for Translational Research Into Neurodegenerative DiseasesJoseph Edward Rittiner, Malik Moncalvo, Ornit Chiba-Falek, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 11, 2021
The Path to Progress Preclinical Studies of Age-Related Neurodegenerative Diseases: A Perspective on Rodent and hiPSC-Derived ModelsGabriella MacDougall, Logan Y Brown, Boris Kantor, et al.
Human Molecular Genetics|February 14, 2004
Control elements within the PWS/AS imprinting box and their function in the imprinting processBoris Kantor, Kirill Makedonski, Yael Green-Finberg, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 24, 2002
Tryptase activates the mitogen-activated protein kinase/activator protein-1 pathway in human peripheral blood eosinophils, causing cytokine production and releaseVladislav Temkin, Boris Kantor, Vivian Weg, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Advances in Genetics|October 15, 2014
Clinical applications involving CNS gene transferBoris Kantor, Thomas McCown, Paola Leone, et al.
Molecular Therapy. Methods & Clinical Development|May 13, 2017
Integrase-Deficient Lentiviral Vector as an All-in-One Platform for Highly Efficient CRISPR/Cas9-Mediated Gene EditingPavel I Ortinski, Bernadette O'Donovan, Xiaoyu Dong, et al.
Life Sciences, Society and Policy|October 12, 2020
Good problems to have? Policy and societal implications of a disease-modifying therapy for presymptomatic late-onset Alzheimer's diseaseMisha Angrist, Anna Yang, Boris Kantor, et al.
Gene|February 6, 2003
Characterization of the human Snrpn minimal promoter and cis elements within itYael Green Finberg, Boris Kantor, Alon Y Hershko, et al.
Pediatric Neurology|July 21, 2020
Viral-Mediated Gene Replacement Therapy in the Developing Central Nervous System: Current Status and Future DirectionsJulie Uchitel, Boris Kantor, Edward C Smith, et al.
Human Molecular Genetics|September 16, 2004
Establishing the epigenetic status of the Prader-Willi/Angelman imprinting center in the gametes and embryoBoris Kantor, Yotam Kaufman, Kirill Makedonski, et al.
Frontiers in Molecular Neuroscience|September 9, 2020
Gene-Editing Technologies Paired With Viral Vectors for Translational Research Into Neurodegenerative DiseasesJoseph Edward Rittiner, Malik Moncalvo, Ornit Chiba-Falek, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 11, 2021
The Path to Progress Preclinical Studies of Age-Related Neurodegenerative Diseases: A Perspective on Rodent and hiPSC-Derived ModelsGabriella MacDougall, Logan Y Brown, Boris Kantor, et al.
Human Molecular Genetics|February 14, 2004
Control elements within the PWS/AS imprinting box and their function in the imprinting processBoris Kantor, Kirill Makedonski, Yael Green-Finberg, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 24, 2002
Tryptase activates the mitogen-activated protein kinase/activator protein-1 pathway in human peripheral blood eosinophils, causing cytokine production and releaseVladislav Temkin, Boris Kantor, Vivian Weg, et al.
Pageof 4